MENU
+Compare
ALDX
Stock ticker: NASDAQ
AS OF
Oct 6 closing price
Price
$5.51
Change
-$0.23 (-4.01%)
Capitalization
330.85M

ALDX Aldeyra Therapeutics Forecast, Technical & Fundamental Analysis

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases... Show more

Industry: #Biotechnology
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALDX with price predictions
Oct 06, 2025

ALDX in upward trend: price rose above 50-day moving average on October 03, 2025

ALDX moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2025. You may want to consider a long position or call options on ALDX as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ALDX just turned positive on October 01, 2025. Looking at past instances where ALDX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALDX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALDX moved out of overbought territory on October 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for ALDX crossed bearishly below the 50-day moving average on September 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALDX broke above its upper Bollinger Band on October 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ALDX entered a downward trend on September 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.984) is normal, around the industry mean (23.464). P/E Ratio (0.000) is within average values for comparable stocks, (54.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.244). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (345.477).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALDX is expected to report earnings to rise 53.13% to -24 cents per share on November 13

Aldeyra Therapeutics ALDX Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Beat
by $0.08
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.01
The last earnings report on August 08 showed earnings per share of -15 cents, beating the estimate of -24 cents. With 705.92K shares outstanding, the current market capitalization sits at 330.85M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Hartwell Avenue
Phone
+1 781 761-4904
Employees
10
Web
https://www.aldeyra.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRTT0.24N/A
+1.01%
Protect Pharmaceutical Corp
HLTRF3.80N/A
N/A
HLS Therapeutics Inc.
IMIAF29.50N/A
N/A
IMI plc
LMPMY3.69N/A
N/A
Lee & Man Paper Manufacturing Ltd.
MTSUY23.78-0.09
-0.38%
Mitsubishi Corp.

ALDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.01%
CANF - ALDX
46%
Loosely correlated
-0.26%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+0.86%
PLRX - ALDX
38%
Loosely correlated
-1.97%
ARVN - ALDX
37%
Loosely correlated
+0.10%
More

Groups containing ALDX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.01%
eye
theme (8 stocks)
40%
Loosely correlated
-1.97%
biotechnology
theme (218 stocks)
22%
Poorly correlated
+0.14%
drugs
theme (233 stocks)
19%
Poorly correlated
+0.26%